Form 4: Charles River Laboratories Director Acquires Shares and Stock Options

Director Craig B. Thompson acquired 559 shares of common stock and 1,311 stock options in Charles River Laboratories on May 13, 2024.

Summary

• On May 13, 2024, Craig B. Thompson, a director of Charles River Laboratories International, Inc., acquired 559 shares of common stock at a price of $228.41 per share.
• Following this transaction, Thompson directly owns 1,467 shares of common stock.
• Thompson also acquired 1,311 stock options with an exercise price of $228.41, which become exercisable on the earlier of May 13, 2025, or the business day prior to the company's next annual meeting of shareholders.
• These options expire on May 13, 2034.
• The unvested restricted stock units vest upon the earlier of 5/13/2025 or the business day prior to the Company's next annual meeting of shareholders.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a routine insider transaction. The director's purchase could be seen as a positive sign, but it's not overwhelmingly indicative of major positive developments.

Positives

• The director's purchase of shares and stock options could be interpreted as a positive signal, indicating confidence in the company's future performance.

Industry Context

Insider transactions are closely monitored as they can provide insights into a company's prospects, although they don't always predict future performance.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment.

Key Dates